[Source: Fierce Pharma ] January 2025 The FDA fast-tracked tirzepatide for cardiovascular risk reduction in obesity patients, following landmark trial results showing significant benefit beyond weight loss
Glucagon-like peptide-1 agonist drugs, such as semaglutide, could save countless lives at risk due to diabetes and obesity
Second, they slow down the rate at which your stomach empties after you eat
Provider supervision matters because a safe plan should include health-history review, medication review, lab evaluation when appropriate, nutrition support, hydration guidance, side-effect monitoring, and follow-up care
For example, if a medication has a half-life of 6 days , that means 50% of the drug is gone 6 days after the injection , 75% is gone by day 12, and so on
It comes in four dose strengths, ranging from 1.5 mg to 25 mg